(en anglais) FDA-approved antibiotic with life-saving potential launches in Puerto Rico – March 14, 2022

(en anglais) Verity Pharmaceuticals and Helsinn Therapeutics sign exclusive agreement for the promotion of Akynzeo^® and Valchlor^® in Puerto Rico – February 16, 2022

(en anglais) Verity Pharmaceuticals and Acerus Pharmaceuticals form commercial agreement for the promotion of Natesto^® in Puerto Rico – January 10, 2022

(en anglais) Critical bladder cancer drug now fully available after years of shortages. Health Canada releases VERITY-BCG™ bladder cancer treatment for distribution – September 9, 2021

(en anglais) Bladder cancer drug shortage resolved with Health Canada approval. VERITY-BCG™ bladder cancer treatment available for Canadian patients in the Spring – February 24, 2021

(en anglais) Debiopharm partners with Verity Pharmaceuticals for the exclusive U.S. commercialization of Trelstar^® for prostate cancer – June 9, 2020

(en anglais) ZEULIDE DEPOT™ is now covered by the Ontario Drug Benefit (ODB) program for patients living with prostate cancer – May 29, 2020